✦ LIBER ✦

Assessment of the immunogenicity and safety of varying doses of an MF59®-adjuvanted cell culture-derived A/H1N1 pandemic influenza vaccine in Japanese paediatric, adult and elderly subjects

✍ Scribed by Hiroyuki Fukase; Hidetoshi Furuie; Yuji Yasuda; Ryoya Komatsu; Kenji Matsushita; Taketsugu Minami; Yutaka Suehiro; Hiroshi Yotsuyanagi; Haruko Kusadokoro; Hiroshi Sawata; Noriko Nakura; Maria Lattanzi

Book ID: 116964865
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 397 KB
Volume: 30
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2012.03.053

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and immunogenicity of an MF59®-ad

Safety and immunogenicity of an MF59®-adjuvanted A/H5N1 pre-pandemic influenza vaccine in adults and the elderly

✍ Timo Vesikari; Aino Forstén; Karl-Heinz Herbinger; Giovanni Della Cioppa; Jenny 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 497 KB

Comparison of half and full doses of an

Comparison of half and full doses of an MF59-adjuvanted cell culture-derived A/H1N1v vaccine in Japanese children

✍ Yuji Yasuda; Ryoya Komatsu; Kenji Matsushita; Taketsugu Minami; Yutaka Suehiro; 📂 Article 📅 2010 🏛 Springer Healthcare Communications 🌐 English ⚖ 395 KB

Immunogenicity, safety and tolerability

Immunogenicity, safety and tolerability of monovalent 2009 pandemic influenza A/H1N1 MF59-adjuvanted vaccine in patients with β-thalassemia major

✍ Susanna Esposito; Emanuela D’Angelo; Cristina Daleno; Francesco Peia; Alessia Sc 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 122 KB

A randomized clinical trial to identify

A randomized clinical trial to identify the optimal antigen and MF59® adjuvant dose of a monovalent A/H1N1 pandemic influenza vaccine in healthy adult and elderly subjects

✍ Christoph Hatz; Frank von Sonnenburg; Daniela Casula; Maria Lattanzi; Geert Lero 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 668 KB

A randomised, single-blind, dose-range s

A randomised, single-blind, dose-range study to assess the immunogenicity and safety of a cell-culture-derived A/H1N1 influenza vaccine in adult and elderly populations

✍ Christoph Hatz; Jakob P. Cramer; André Vertruyen; Tino F. Schwarz; Frank von Son 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 376 KB

Safety and immunogenicity of an adjuvant

Safety and immunogenicity of an adjuvanted whole virion, inactivated A (H1N1) 2009 influenza vaccine in young and elderly adults, and children

✍ Prasad S. Kulkarni; K. Manjunath; Sharad Agarkhedkar 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 148 KB